Hershey shares jump after strong Q4, optimistic 2026 outlook

Hershey reported stronger-than-expected Q4 results with adjusted EPS of $1.71 versus consensus $1.40 (though down 36.4% year-over-year from $2.69) and revenue up 7% to $3.09 billion versus a $2.98 billion forecast; net income was $320 million. Sales were driven by higher pricing, acquisitions and new product launches, offset by margin pressure from rising commodity and tariff costs; Jefferies highlighted beats to sales, EBIT and EPS (~4%, ~23%, ~23%). Management issued a robust 2026 outlook, projecting midpoints for net sales and EPS roughly 2% and 18% above consensus, supported by pricing power, innovation and cost savings — a combination that sent shares up ~7.7% on the news.

Analysis

Market structure: Hershey (HSY) benefits most—near-term pricing power, innovation cadence and M&A are supporting ~7% revenue beat and management’s 2026 guide (+~2% sales, +18% EPS vs consensus midpoint). Competitors with weaker innovation or higher commodity exposure (e.g., MDLZ, KHC) risk share loss in premium confection/salty snacks; private-label pressure remains a loser if pricing overreaches. Cross-asset: expect modest tightening in HSY credit spreads (investment grade), lower equity IV after the pop, and renewed sensitivity of cocoa/sugar futures to company commentary (commodity moves will feed back into margin expectations).

Risk assessment: Tail risks include a >20% cocoa/sugar shock from weather or supply curbs, tariff escalation on imports, or acquisition integration that erodes margin synergies—each could wipe 10–25% off EPS versus guide. Timing: immediate (days) — volatility and price reversion; short-term (3–6 months) — realization of cost saves and promotional cadence; long-term (12–24 months) — whether organic volume growth sustains. Hidden dependencies: retailer slotting/promotional cadence, hedge book roll schedules, and tariff/tax policy shifts. Key catalysts: monthly cocoa futures, quarterly retail scan data, and FY2026 cadence updates.

trade implications: Direct: establish a 1–3% long HSY core position for 6–12 months targeting 12–18% upside if EPS execution continues; use 6–9 month calls (delta 0.35–0.45) to lever with defined risk. Pair: long HSY vs short MDLZ (equal notional) for relative outperformance, horizon 6–12 months. Options hedges: buy 3–6 month puts (delta 0.25–0.35) sized 30–40% of equity exposure as insurance. Rotate modestly into staples from discretionary if macro softens; monitor cocoa >+15% YTD as a trigger to trim.

contrarian angles: Consensus under-weights the risk that current EPS beats are driven by pricing and acquisitions not durable volume recovery — if consumer elasticity bites, volumes could compress and margins re-open. The market may be underpricing margin cyclicality: historical cocoa spikes produced ~15–25% EPS downside in food peers within 12 months. If HSY’s cost-savings milestones miss by >50bps in COGS, downside is underappreciated; incorporate option hedges and staged scaling rather than all-in buys.

Key Decisions for Investors

• Establish a 1–3% portfolio long position in HSY (NYSE:HSY) over 1–3 trading days; target 12–18% upside over 6–12 months, place a stop-loss at -8% from entry or hedge with 30–40% notional of 3–6 month puts (delta 0.25–0.35).
• Implement a relative-value pair: long HSY vs short MDLZ (Mondelez) equal notional size for a 6–12 month horizon, expecting HSY to outperform by 6–12% if pricing/innovation translate to market-share gains.
• Use options to lever upside with defined risk: buy 6–9 month call spreads on HSY at ~0.35–0.45 delta long leg (size to equal 50–100% of desired equity exposure) instead of naked stock to cap capital at risk.
• Monitor cocoa futures and retail scan data closely: if cocoa rises >15% YTD or monthly change >10% within 90 days, reduce HSY exposure by half and increase put hedge size; conversely, add to HSY on a pullback of 5–8% within 10 trading days post-earnings.